Tsuda, Yasumasa http://orcid.org/0000-0001-7343-0982
Takahashi, Masahiro
Watanabe, Fumiya
Goto, Kazumi
Echizen, Hirotoshi
Article History
Accepted: 7 August 2023
First Online: 11 September 2023
Change Date: 18 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13318-024-00890-8
Declarations
:
: This study received no external funding.
: The authors declare no conflicts of interest directly relevant to the content of the present study.
: All software used in the present study is commercially available and the necessary information was given in the text.
: The study protocol was approved by the Research Ethics Committee of St. Luke’s International Hospital (approval number 16-074).
: Written informed consent from participating patients was waived because all blood samples for TDM were obtained for therapeutic purposes as well as other medical procedures under the comprehensive agreement of patients. The opt-out statement for the present study was disclosed to the hospital’s public statement board.
: Not applicable.
: The original code of the population pharmacokinetic model may be available upon a reasonable request from the corresponding author.
: YT, MT, and FW designed the research. YT collected the data. YT and MT performed the data analysis and the pharmacokinetic analysis. YT wrote the draft manuscript. YT, MT, FW, KG, and HE substantially contributed to revising the manuscript drafts. All authors approved the final version of the manuscript.